Analyst Activity – Maxim Group Initiates Coverage On Atossa Genetics (NASDAQ:ATOS) With a Buy

Analyst Ratings For Atossa Genetics (NASDAQ:ATOS)

Story continues below

Today, Maxim Group initiated coverage on Atossa Genetics (NASDAQ:ATOS) with a Buy with a price target of $2.00.

Some recent analyst ratings include

  • 1/26/2018-Maxim Group initiated coverage with a Buy rating.

Recent Insider Trading Activity For Atossa Genetics (NASDAQ:ATOS)
Atossa Genetics (NASDAQ:ATOS) has insider ownership of 5.60% and institutional ownership of 2.84%.

  • On 11/15/2017 Kyle Guse, CFO, bought 10,000 with an average share price of $0.34 per share and the total transaction amounting to $3,400.00.
  • On 4/17/2017 H. Lawrence Remmel, Director, bought 2,500 with an average share price of $0.63 per share and the total transaction amounting to $1,575.00.
  • On 4/1/2016 H. Lawrence Remmel, Director, bought 1,500 with an average share price of $0.33 per share and the total transaction amounting to $495.00.
  • On 3/9/2016 Steven C Quay, CEO, bought 15,000 with an average share price of $0.37 per share and the total transaction amounting to $5,550.00.
  • On 2/16/2016 Shu-Chih Chen, Director, bought 15,000 with an average share price of $0.53 per share and the total transaction amounting to $7,950.00.
  • On 1/19/2016 Steven C Quay, CEO, bought 50,000 with an average share price of $0.20 per share and the total transaction amounting to $10,000.00.
  • On 6/12/2015 H. Lawrence Remmel, Director, bought 5,400 with an average share price of $1.30 per share and the total transaction amounting to $7,020.00.

Recent Trading Activity for Atossa Genetics (NASDAQ:ATOS)
Shares of Atossa Genetics closed the previous trading session at with shares trading hands.

An ad to help with our costs